# Imagin Medical Inc. (IMEXF)

> Healthcare · CA · Reports in CAD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/IMEXF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2023 | $ 0 | $ 1.38M | $ -484.3K | $ 10.98M | $ -11.96M |
| 2022 | $ 0 | $ -1.24M | $ -3.01M | $ 12.91M | $ -13.31M |
| 2021 | $ 0 | $ -13.95M | $ -4.53M | $ 12.53M | $ -12.49M |
| 2020 | $ 0 | $ -4.43M | $ -4.60M | $ 853.2K | $ -866.6K |
| 2019 | $ 0 | $ -5.64M | $ -5.16M | $ 0 | $ 870.5K |
| 2018 | $ 0 | $ -9.48M | $ -5.39M | $ 0 | $ 5.51M |
| 2017 | $ 0 | $ -2.91M | $ -1.76M | $ 38.0K | $ 1.78M |
| 2016 | $ 0 | $ -3.45M | $ -2.40M | $ 0 | $ 189.7K |
| 2015 | $ 0 | $ -363.4K | $ -257.7K | $ 0 | $ -148.4K |
| 2014 | $ 0 | $ -2.68M | $ -873.6K | $ 0 | $ 120.9K |
| 2013 | $ 0 | $ -599.2K | $ -752.2K | $ 0 | $ 2.14M |
| 2012 | $ 0 | $ -2.63M | $ -1.21M | $ 0 | $ 2.56M |
| 2011 | $ 0 | $ -3.56M | $ -2.97M | $ 0 | $ 4.23M |
| 2010 | $ 0 | $ 1.68M | $ -1.44M | $ 0 | $ 3.76M |
| 2009 | $ 0 | $ -7.74M | $ -1.30M | $ 99.9K | $ 2.43M |
| 2008 | $ 0 | $ -12.06M | $ -3.39M | $ 0 | $ 7.77M |
| 2007 | $ 0 | $ -3.31M | $ -7.37M | $ 0 | $ 14.53M |
| 2006 | $ 0 | $ -2.21M | $ -6.98M | $ 0 | $ 11.12M |
| 2005 | $ 0 | $ -1.67M | $ 1.06M | $ 0 | $ 3.16M |
| 2004 | $ 371 | $ -785.6K | $ -199.1K | $ 191.2K | $ 202.1K |
| 2003 | $ 1.3K | $ -700.9K | $ -43.8K | $ 64.4K | $ 354.2K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.92 |
| Liabilities / Eq | -1.09 |
| Current Ratio | 0.01 |

## Other views

- [Metrics](https://sponda.capital/en/IMEXF.md)
- [Charts](https://sponda.capital/en/IMEXF/charts.md)
- [Compare](https://sponda.capital/en/IMEXF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.
